These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26387684)

  • 1. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
    Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
    Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
    Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
    Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.
    Galeva S; Konstantinidou L; Gil MM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Feb; 53(2):208-213. PubMed ID: 30353581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES].
    Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A
    Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the neoBona test: a new paired-end massively parallel shotgun sequencing approach for cell-free DNA-based aneuploidy screening.
    Cirigliano V; Ordoñez E; Rueda L; Syngelaki A; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):460-464. PubMed ID: 27981672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
    Kagan KO; Eiben B; Kozlowski P
    Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.